Monetizing AI & Machine Learning Applications in Life Sciences

11:00 AM - 12:00 PM (PDT), Tuesday, June 14, 2022

Life sciences and healthcare companies are leveraging machine learning and AI for new advancements. Join senior executives and dealmakers from 23andMe and leading biotechnology and biopharma companies to learn how they are successfully commercializing and implementing monetization strategies surrounding AI and machine learning. Discussion topics will include, but are not limited to, dealmaking considerations as well as licensing, data, and regulatory issues associated with the technology.

Moderator
photo
Partner
Cooley
Speakers
photo
Director, Business Development
23andMe
photo
CEO and Co-founder
BigHat Biosciences
photo
CEO
Zephyr AI
photo
CEO and Founder
Onc.AI